Equities

HST Global Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
HSTC:PKC

HST Global Inc

Actions
  • Price (USD)0.50
  • Today's Change0.00 / 0.00%
  • Shares traded500.00
  • 1 Year change-3.86%
  • Beta-0.8733
Data delayed at least 15 minutes, as of Feb 26 2026 20:59 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

HST Global, Inc. is an integrated health and wellness biotechnology company. The Company is focused on developing and /or acquiring a network of wellness centers worldwide that is primarily focused on the homeopathic and alternative treatment of late-stage cancer. The Company intends to acquire innovative products for the treatment of life-threatening diseases. The Company primarily focuses on homeopathic and alternative product candidates that are undergoing or have already completed clinical testing for the treatment of late-stage cancer and/or life-threatening diseases. It is also focused on funding and developing cutting-edge software solutions. The Company has not generated any revenue.

  • Revenue in USD (TTM)0.00
  • Net income in USD-212.63k
  • Incorporated2004
  • Employees1.00
  • Location
    HST Global Inc509 Old Great Neck Road, Suite 105VIRGINIA BEACH 23454United StatesUSA
  • Phone+1 (757) 766-6100
  • Websitehttp://www.hstglobal.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Q32 Bio Inc0.00-42.10m66.23m26.00---------3.45-3.450.00-1.500.00----0.00-51.87-36.08-61.53-39.62-------870.34---------100.00--57.74---67.85--
Grace Therapeutics, Inc0.00-5.98m66.38m32.00--1.02-----0.3607-0.36070.004.190.00-------9.22-24.13-9.46-25.07-------48,136.22----0.00------25.56------
XBiotech Inc0.00-29.16m68.90m88.00--0.4124-----0.9566-0.95660.005.480.00----0.00-15.25-7.74-16.08-8.02-------187.68----0.00-------56.90--44.92--
Coeptis Therapeutics Holdings Inc500.99k-11.28m69.35m5.00--5.99--138.42-3.47-3.470.14762.010.0433--11.65100,198.00-118.13-42.24-167.86-44.3272.96---2,727.81-----73.660.0224------53.85------
Adicet Bio Inc0.00-115.01m69.44m152.00--0.3456-----20.22-20.220.0020.980.00----0.00-59.52-36.24-66.08-39.41-------813.80----0.0088------17.90--32.77--
HST Global Inc0.00-212.63k70.56m1.00--4.28-----0.0107-0.01070.000.11670.00-------6.87-27.80-8.09-60.19-----------107.480.0433-------45.42------
Annovis Bio Inc0.00-24.88m71.03m8.00--4.11-----1.41-1.410.000.65170.00----0.00-157.74-116.87-221.93-138.75------------0.00------56.25------
Medicinova Inc257.92k-12.01m71.37m13.00--1.62--276.72-0.2449-0.24490.00530.89640.0049----19,840.00-22.73-15.56-24.08-16.17-----4,656.61-1,144.98----0.00---100.00---28.91---39.68--
Fractyl Health Inc3.00k-122.20m71.98m107.00------23,992.50-2.27-2.270.00006-0.0240.00002----28.04-101.33-78.52-118.18-97.44100.00---4,073,233.00-122,747.90---31.401.12---22.50--25.29--78.65--
Nuo Therapeutics Inc2.61m-2.43m72.42m--------27.73-0.0517-0.05170.0555-0.00881.434.195.32---133.29-121.45-289.99-243.0570.3878.52-93.06-424.191.00-17,110.33----124.3456.3426.73------
Protext Mobility Inc750.00-2.21m72.53m4.00------96,703.44-0.4692-0.46920.00001-0.01020.0405-------9,400.97-1,587.94----86.67-530.19-232,392.00-17,498.830.0002-1.36-----93.98-63.0927.35------
eXoZymes Inc0.00-8.34m74.34m31.00--13.81-----1.76-1.760.000.64080.00----0.00-147.87---393.50--------------0.0217-------187.55------
Tenax Therapeutics Inc0.00-43.33m74.92m4.00--0.7368-----1.13-1.130.0016.290.00----0.00-42.77-99.65-44.80-118.65------------0.00-------128.28------
ImageneBio Inc0.00-46.14m75.14m15.00--0.5374-----8.11-8.110.0012.510.00----0.00-29.23-29.58-31.29-33.67-------407.25----0.00---100.00--27.77------
Data as of Feb 26 2026. Currency figures normalised to HST Global Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.